📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

TGFß1 induces resistance of human lung myofibroblasts to cell death via down-regulation of TRPA1 channels. (2021)

First Author: Virk HS

Attributed to: TRPA1; a potential therapeutic target in idiopathic pulmonary fibrosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.15467

PubMed Identifier: 33786825

Publication URI: http://europepmc.org/abstract/MED/33786825

Type: Journal Article/Review

Volume: 178

Parent Publication: British journal of pharmacology

Issue: 15

ISSN: 0007-1188